kazia therapeutics - Robuta Search

https://www.prnewswire.com/news-releases/kazia-therapeutics-expands-oncology-platform-with-first-in-class-setdb1-inhibitor-drug-development-platform-302740954.html Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development... /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome... first in class kazia therapeutics drug development expands oncology https://www.salamancapress.com/2024/12/31/kazia-therapeutics-provides-update-on-paxalisib-regulatory-pathway-following-type-c-meeting-with-fda/ Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with... Jan 1, 2025 - SYDNEY, Dec. 31, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today provided a regulatory... kazia therapeutics provides update regulatory pathway https://pharmasource.global/content/news/cro-news/kazia-therapeutics-leverages-cro-strategy-to-advance-setdb1-oncology-program/ Kazia Therapeutics Leverages CRO Strategy to Advance SETDB1 Oncology Program - PharmaSource Apr 14, 2026 - Kazia Therapeutics Limited announced plans to advance its newly in-licensed SETDB1 oncology program in parallel with its PD-L1 degrader platform, leveraging... kazia therapeutics oncology program cro strategy advance https://biopharmaapac.com/news/76/7502/kazia-therapeutics-reports-encouraging-early-responses-for-paxalisib-combination-in-advanced-triple-negative-breast-cancer.html Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple... Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer kazia therapeutics reports encouraging early responses https://www.ibisworld.com/australia/company/kazia-therapeutics-limited/459855/ Kazia Therapeutics Limited - Company Profile Report | IBISWorld Access a detailed company profile for Kazia Therapeutics Limited. Includes financial data, executive team, industry roles, and service providers. Download your... kazia therapeutics limited company profile report ibisworld https://marketxls.com/dividend-calculator/KZIA Kazia Therapeutics Limited (KZIA) Dividend Calculator | MarketXLS Kazia Therapeutics Limited (KZIA) does not currently pay a dividend. Use our dividend calculator for other stocks. kazia therapeutics dividend calculator limited kzia https://vir.com.vn/kazia-therapeutics-appoints-sudha-rao-as-chief-scientific-officer-150724.html Kazia Therapeutics appoints Sudha Rao as chief scientific officer Apr 16, 2026 - The Australian oncology drug developer named Rao to lead research and development for its cancer therapy pipeline. kazia therapeutics sudha rao chief scientific https://www.clinicaltrialsarena.com/news/kazia-therapeutics-alliance-oncology/ Kazia Therapeutics, Alliance collaborate on oncology treatment trials May 20, 2019 - Kazia Therapeutics has collaborated with the Alliance for Clinical Trials in Oncology Foundation on clinical trials for metastatic brain cancer treatment. kazia therapeutics oncology treatment alliance collaborate trials https://charts.equityclock.com/kazia-therapeutics-ltd-nasdkzia-seasonal-chart Kazia Therapeutics Ltd. (NASD:KZIA) Seasonal Chart | Equity Clock kazia therapeutics seasonal chart equity clock ltd nasd https://www.egsllp.com/featured-deals/kazia-therapeutics-limited Kazia Therapeutics Limited - Ellenoff Grossman & Schole LLP kazia therapeutics limited grossman llp https://www.finnewsnetwork.com.au/CompanyReports/Kazia-Therapeutics/0 Company Report - Kazia Therapeutics company report kazia therapeutics https://ca.marketscreener.com/quote/stock/KAZIA-THERAPEUTICS-LIMITE-45081120/news/Kazia-Therapeutics-Limited-announced-that-it-expects-to-receive-15-million-in-funding-from-Alumni-C-46483535/ Kazia Therapeutics Limited announced that it expects to receive $15 million in funding from Alumni... Apr 19, 2024 - Kazia Therapeutics Limited announced that it has entered into purchase agreement with new investor, Alumni Capital LP to issue fully paid ordinary shares, no... kazia therapeutics limited announced receive million https://stocknews.ai/ai-news/what-s-going-on-with-cancer-firm-kazia-therapeutics/692f2487234b2e28e147c965 What's Going On With Cancer Firm Kazia Therapeutics | StockNews.AI Kazia Therapeutics Limited (NASDAQ: KZIA) announced a private placement of approximately $50 million... going on with cancer kazia therapeutics firm ai